Abstract:Folate-modified carboxymethyl chitosan (FCMC) was made by folate acid as targeted group and attaching folate to carboxymethyl chitosan, and then, targeted FCMC/CaCO3 hybrid nanosphere were formed by self-assembly of calcium carbonate in FCMC solution. The physicochemical properties of the nanospheres were investigated by Fourier transform infrared spectroscopy, X-ray diffraction analysis, Brunauer-Emmett-Teller measurement and thermogravimetric analysis (TGA). The results showed that the FCMC/CaCO3 hybrid nanospheres were composed of calcite, vaterite and polysaccharides, and the content of organic compounds was 12.17%. Also, the structure performance of the hybrid nanospheres was analyzed. Besides, the effects of the hybrid nanospheres on the encapsulation efficiency, the drug loading content and the release behavior were also analyzed with the metformin (MET) as a model drug. Scanning electron microscope, Zeta potential analysis and UV-Vis were used to characterize the hybrid nanospheres. Under the conditions of FCMC/Ca2+ molar ratio of 4: 1 and reaction for 24 h, the achieved results showed that the spherical aggregates with regular morphology were obtained and the average particle size of the nanospheres was 207 nm. The specific surface area of the hybrid nanosphere is 27.06 m2·g-1 and the average pore diameter of the sample is 3.84 nm, indicating the presence of mesoporous structure in the sample. This mesoporous structure can supply potential space for adsorption of anticancer drugs. Additionally, the surface charge of the nanoparticles was positive and the entrapment efficiency was 83.32%. The hybrid nanospheres have a capability of effective pH-sensitivity controlled drug release. All the drug loaded hybrid nanospheres successfully sustained the release of MET at pH 7.4, only about 44.58% of the drug released in 6 days. While under acidic condition (pH 5.0) drug release was significantly accelerated, being over 98.85% of the drug released. The hybrid nanospheres demonstrated an excellent smart drug delivery behavior.

Technology Optimization of Sustained-Realeasing Chitosan Microspheres Loaded with Ferulic Acid and Their Drug-Releasing Mechanism

[Preparation and in Vitro Drug Release of Ferulic Acid Loaded Chitosan Microspheres Containing Liposomes].

Preparation of drug-loaded chitosan microspheres repair materials

Studies on preparation of diclofenac sodium silk fibroin-chitosan sustained-release microspheres and its characteristics

Preparation and performance of pravastatin sodium-loaded chitosan microspheres

Preparation of Genistein-Chitosan Microspheres and their Drug-Releasing Performances

Preparation of ternary hybridized chitosan microspheres with photothermal effect for pH-sensitive long-lasting controlled release system and its release mechanism

Efficient synthesis strategy of folate-modified carboxymethyl chitosan/CaCO3 hybrid nanospheres and their drug-carrying and sustained release properties

Evaluation of chitosan-ferulic acid microcapsules for sustained drug delivery: Synthesis, characterizations, and release kinetics in vitro

Process Optimization of Chitosan Microspheres Preparation Technology by Uniform Design

Preparation and improvement of release behavior of chitosan microspheres containing insulin.

Chitosan-graft-poly(lactic acid)/CD-MOFs degradable composite microspheres for sustained release of curcumin

Preparation and Drug Releasing Property of Magnetic Fluorouracil-loaded Chitosan Microspheres

Preparation of 5-fluorouracil loaded chitosan/fibroin blend magnetic microspheres and its properties in vitro

Formulation optimization of chelerythrine loaded O-carboxymethylchitosan microspheres using response surface methodology

Optimization on Preparation Conditions of Calcium-Crosslinked Modified Chitosan As Potential Matrix Material for Theophylline Sustained-Release Beads and Its Evaluation of Release Kinetics

Preparation and characterization of functional lysozyme loaded microspheres

Study on Pharmacokinetics of Ferulic Acid Loaded Liposome- In-Chitosan-microspheres in Rats

Application of Central Composite Design-Based Response Surface Methodology in Optimization of the Preparation Process of Sanguinarine Chitosan Microspheres

Preparation of Levodopa-Chitosan Microspheres and The Drug-Release Performance

Central Composite Design Optimizes Preparation of Norcantharidin-Loaded Chitosan-Fibroin Microspheres for Embolization